It Is Premature to Reduce Linezolid Doses in Patients With Impaired Kidney Function
- PMID: 38113482
- DOI: 10.1093/cid/ciad771
It Is Premature to Reduce Linezolid Doses in Patients With Impaired Kidney Function
Conflict of interest statement
Potential conflicts of interest. R. C. M. reports clinical trial support (paid to his institution) from AiCuris, Sound Pharmaceuticals, Biotest, and GeoVax; honoraria for scientific advisory panel membership from Shionogi, all unrelated to the contents of this manuscript; travel support from the Society of Critical Care Medicine and the American College of Chest Physicians for committee work; and roles as chair, FCCS for the Crisis Management Committee (unpaid) of the Society of Critical Care Medicine and as chair for the Disaster Response and Global Health Section (unpaid) of the American College of Chest Physicians. The author has submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Conflicts that the editors consider relevant to the content of the manuscript have been disclosed.
Comment on
-
Central Nervous System Infections and Antibiotic Selection: All Infection Sites Are Not Created Equal.Clin Infect Dis. 2024 Aug 16;79(2):573-574. doi: 10.1093/cid/ciad772. Clin Infect Dis. 2024. PMID: 38113485 No abstract available.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical